Javle, M., Lowery, M., Shroff, R. T., Weiss, K. H., Springfeld, C., Borad, M. J., . . . Bekaii-Saab, T. (2018). Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma. J Clin Oncol.
Chicago-stil citatJavle, Milind, et al. "Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma." J Clin Oncol 2018.
MLA-referensJavle, Milind, et al. "Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma." J Clin Oncol 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.